The Greek government has passed a draft bill to leglise medical cannabis through the parliamentary committee stage
Five Florida nurseries, including two from Miami-Dade County, were selected Monday to cultivate and distribute the first legal marijuana in the state, opening the door to the sale of the non-euphoric strains to treat patients with seizure disorders and cancer by June of next year.
The House stripped some requirements out of the bill for CBD manufacturers and made it a level 5 felony to knowingly sell CBD oil with a higher amount of THC, labeled as low-THC.
Canada is on the cusp of an unprecedented change in its governmental approach to recreational cannabis consumption. By July of 2018 the country will legalize and regulate recreational cannabis use across the country via the implementation of the Cannabis Act, representing the second country in the world and the first in North America to do so. As other countries around the world struggle with illegal cannabis consumption, the Canadian example and novel regulatory scheme could prove a useful guiding tool for future policy in other jurisdictions. The following paper discusses key areas to watch and a brief intro of how Canada got to where it is and the foundational need for a shift in policy.
“They all tell us their own stories and we design their own little scripts and pictures that go along with it,” said Stewart, who runs the Mood, Anxiety, and Addiction Co-morbidity (MAAC) lab at Dal’s Department of Psychology and Neuroscience.
“It’s heartening to see that this fairly large proportion achieved that degree of reduction in their pain assessment score,
The bill would revise certain requirements concerning patient access to medical marijuana. Specifically, it provides for alternative treatment centers to make medical marijuana available to patients in oil form, removes restrictions that made edible forms of medical marijuana available only to qualifying patients who are minors, and removes the current 2-ounce limit on the quantity of medical marijuana that may be dispensed in a 30-day supply.
“We were up against big monied interests that are pumping hundreds of thousands of dollars into campaign coffers and lobbyists in order to thwart our goals of making an equitable industry. But in the end we came out on top,”
Cannabis has been employed medicinally throughout history, but its recent legal prohibition, biochemical complexity and variability, quality control issues, previous dearth of appropriately powered randomised controlled trials, and lack of pertinent education have conspired to leave clinicians in the dark as to how to advise patients pursuing such treatment. Suggestions are offered on cannabis-drug interactions, patient monitoring, and standards of care, while special cases for cannabis therapeutics are addressed: epilepsy, cancer palliation and primary treatment, chronic pain, use in the elderly, Parkinson disease, paediatrics, with concomitant opioids, and in relation to driving and hazardous activities.
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer
Cancer is a major public health problem as the leading cause of death. Palliative treatment aimed to alleviate pain and nausea in patients with advanced disease is a cornerstone of oncology. In 2007, the Israeli Ministry of Health began providing approvals for medical cannabis for the palliation of cancer symptoms. The aim of this study is to characterize the epidemiology of cancer patients receiving medical cannabis treatment and describe the safety and efficacy of this therapy. Cannabis as a palliative treatment for cancer patients seems to be well tolerated, effective and safe option to help patients cope with the malignancy related symptoms.